BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 28618942)

  • 1. Erratum: Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis.
    JCO Precis Oncol; 2023 Sep; 7():e2300383. PubMed ID: 37656953
    [No Abstract]   [Full Text] [Related]  

  • 2. Promises of Fibroblast Growth Factor Receptor-Directed Therapy in Tailored Cancer Treatment.
    Fagoonee S; Pellicano R
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32784393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma.
    Pikul J; Rzepakowska A; Machnicki M; Stokłosa T
    Contemp Oncol (Pozn); 2023; 27(3):211-216. PubMed ID: 38239864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An FGFR2 mutation as the potential cause of a new phenotype including early-onset osteoporosis and bone fractures: a case report.
    Dantsev IS; Parfenenko MA; Radzhabova GM; Nikolaeva EA
    BMC Med Genomics; 2023 Dec; 16(1):329. PubMed ID: 38098042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer.
    Yoon CI; Ahn SG; Cha YJ; Kim D; Bae SJ; Lee JH; Ooshima A; Yang KM; Park SH; Kim SJ; Jeong J
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer.
    Minashi K; Yamada T; Hosaka H; Amagai K; Shimizu Y; Kiyozaki H; Sato M; Soeda A; Endo S; Ishida H; Kamoshida T; Sakai Y; Shitara K
    Jpn J Clin Oncol; 2021 Oct; 51(10):1523-1533. PubMed ID: 34258618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review.
    Wang Y; Zhong X; Zhou L; Lu J; Jiang B; Liu C; Guo J
    Front Oncol; 2020; 10():1466. PubMed ID: 33042793
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma.
    Braun M; Piasecka D; Tomasik B; Mieczkowski K; Stawiski K; Zielinska A; Kopczynski J; Nejc D; Kordek R; Sadej R; Romanska HM
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32971804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence.
    Zhou C; Zhong X; Song Y; Shi J; Wu Z; Guo Z; Sun J; Wang Z
    Front Oncol; 2019; 9():1321. PubMed ID: 31850212
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome-Wide Association Mapping and Gene Expression Analyses Reveal Genetic Mechanisms of Disease Resistance Variations in
    Zhou Q; Su Z; Li Y; Liu Y; Wang L; Lu S; Wang S; Gan T; Liu F; Zhou X; Wei M; Liu G; Chen S
    Front Genet; 2019; 10():1167. PubMed ID: 31824570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.
    Ferencz S; Reglodi D; Kaszas B; Bardosi A; Toth D; Vekony Z; Vicena V; Karadi O; Kelemen D
    Oncol Lett; 2019 Dec; 18(6):5725-5730. PubMed ID: 31788045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic and prognostic impacts of
    Kim HS; Kim JH; Jang HJ
    J Cancer; 2019; 10(11):2560-2567. PubMed ID: 31258762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of genetic variants in
    Yang Y; Fei M; Zhou X; Li Y; Jin D
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113874
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis.
    Kim HS; Kim JH; Jang HJ; Han B; Zang DY
    J Cancer; 2019; 10(1):20-27. PubMed ID: 30662521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.
    Ortega-Bernal D; La Rosa CHG; Arechaga-Ocampo E; Alvarez-Avitia MA; Moreno NS; Rangel-Escareño C
    Oncol Lett; 2018 Aug; 16(2):1899-1911. PubMed ID: 30008882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis.
    Liu G; Xiong D; Xiao R; Huang Z
    Tumour Biol; 2017 Jun; 39(6):1010428317707424. PubMed ID: 28618942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
    Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
    Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
    Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
    Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
    Ye C; Wang J; Wu P; Li X; Chai Y
    Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.